Results 221 to 230 of about 14,237 (239)
Some of the next articles are maybe not open access.
Journal of Agricultural and Food Chemistry, 2018
A ratiometric near-infrared fluorescence probe based on IR-780 is developed and applied to fluoride anion (F-) detection in potable water and white flour as well as fluorescence imaging in living cells and mice. The proposed probe not only displays a linear ratiometric (F740/F690 nm) fluorescence response but also possesses near-infrared wavelengths to
Xinwei Tian +5 more
openaire +2 more sources
A ratiometric near-infrared fluorescence probe based on IR-780 is developed and applied to fluoride anion (F-) detection in potable water and white flour as well as fluorescence imaging in living cells and mice. The proposed probe not only displays a linear ratiometric (F740/F690 nm) fluorescence response but also possesses near-infrared wavelengths to
Xinwei Tian +5 more
openaire +2 more sources
Analytical Chemistry, 2019
The matrix plays a prominent role in expanding the ability of matrix assisted laser desorption/ionization mass spectrometry (MALDI MS). However, on account of the unclarity of necessary properties of the matrix in MALDI MS, development of a new matrix is still in the exploratory stage and lacks systematic theoretical guidance.
Na Li +8 more
openaire +2 more sources
The matrix plays a prominent role in expanding the ability of matrix assisted laser desorption/ionization mass spectrometry (MALDI MS). However, on account of the unclarity of necessary properties of the matrix in MALDI MS, development of a new matrix is still in the exploratory stage and lacks systematic theoretical guidance.
Na Li +8 more
openaire +2 more sources
Current Cancer Drug Targets
Background:: Immune-checkpoint inhibitors (ICIs) against programmed death (PD)-1/PD-L1 pathway immunotherapy have been demonstrated to be effective in only a subset of patients with cancer, while the rest may exhibit low response or may develop drug resistance after initially responding.
Wei, Yang +8 more
openaire +2 more sources
Background:: Immune-checkpoint inhibitors (ICIs) against programmed death (PD)-1/PD-L1 pathway immunotherapy have been demonstrated to be effective in only a subset of patients with cancer, while the rest may exhibit low response or may develop drug resistance after initially responding.
Wei, Yang +8 more
openaire +2 more sources